Image_1_PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced Obesity.TIF
Background: Plasminogen activator inhibitor (PAI)-1 levels and activity are known to increase during metabolic syndrome and obesity. In addition, previous studies have implicated PAI-1 in adipose tissue (AT) expansion while also contributing to insulin resistance. As inflammation is also known to occur in AT during obesity, we hypothesized that in a high-fat diet (HFD)-induced obese mouse model PAI-1 contributes to macrophage-mediated inflammation and metabolic dysfunction.
Methods: Four- to five-weeks-old male C57B6/6J mice were fed a HFD (45%) for 14 weeks, while age-matched control mice were fed a standard laboratory chow diet (10% fat). Additional studies were performed in PAI-1 knockout mice and wild type mice treated with an inhibitor (PAI-039) of PAI-1. Macrophage polarization were measured by real time PCR.
Results: HFD mice showed increased expression of PAI-1 in visceral white AT (WAT) that also displayed increased macrophage numbers. PAI-1 deficient mice exhibited increased numbers of anti-inflammatory macrophages in WAT and were resistant to HFD-induced obesity. Similarly, pharmacological inhibition of PAI-1 using PAI-039 significantly decreased macrophage infiltration in WAT and improved metabolic status in HFD-induced wild-type mice. Importantly, the numbers of M1 macrophages appeared to be increased by the HFD and decreased by either genetic PAI-1 depletion or PAI-039 treatment.
Conclusions: Collectively, our findings provide support for PAI-1 contributing to the development of inflammation in adipose tissue and explain the mechanism of inflammation modulated by PAI-1 in the disordered metabolism in HFD-induced obesity.
History
References
- https://doi.org//10.1161/01.ATV.0000242905.41404.68
- https://doi.org//10.1017/S0007114512001171
- https://doi.org//10.1097/MOL.0b013e3283346ccc
- https://doi.org//10.1007/s00125-016-3904-9
- https://doi.org//10.1038/sj.emboj.7601082
- https://doi.org//10.1172/JCI116892
- https://doi.org//10.2337/diacare.21.11.1967
- https://doi.org//10.1038/nri3071
- https://doi.org//10.1016/S0021-9150(98)00281-0
- https://doi.org//10.1074/jbc.M606214200
- https://doi.org//10.1021/jm049766q
- https://doi.org//10.1007/s001250050868
- https://doi.org//10.1161/01.ATV.13.2.162
- https://doi.org//10.2337/db08-1475
- https://doi.org//10.1002/oby.21003
- https://doi.org//10.1016/j.soard.2010.05.013
- https://doi.org//10.1161/CIRCRESAHA.107.160630
- https://doi.org//10.1126/science.7678183
- https://doi.org//10.1161/ATVBAHA.113.301224
- https://doi.org//10.1056/NEJM200006153422406
- https://doi.org//10.1172/JCI29881
- https://doi.org//10.2337/diabetes.53.2.336
- https://doi.org//10.1161/01.ATV.20.4.1150
- https://doi.org//10.1002/path.3992
- https://doi.org//10.2337/db14-1174
- https://doi.org//10.1210/en.2008-0971
- https://doi.org//10.1073/pnas.96.12.6902
- https://doi.org//10.1096/fj.00-0750fje
- https://doi.org//10.1152/ajpendo.00050.2010
- https://doi.org//10.1172/JCI200319246
- https://doi.org//10.1161/ATVBAHA.114.304554
- https://doi.org//10.1172/JCI200319451